Home › Overweight › Indiana › Indianapolis
Pag-aaral pangklinika para sa Overweight sa Indianapolis, IN
Isang pag-aaral para sa Overweight ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Indianapolis. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Nagre-recruitPhase 3
- IU Health - Riley Physicians Endo-Diab, Indianapolis
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Nagre-recruitPhase 3
- Midwest Inst For Clin Res, Indianapolis
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Nagre-recruitPhase 3
- Midwest Inst For Clin Res, Indianapolis
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Nagre-recruitPhase 3
- Indiana University Health University Hospital, Indianapolis
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Nagre-recruitPhase 3
- Riley Hospital for Children, Indianapolis
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Nagre-recruitPhase 3
- Indiana University Health University Hospital, Indianapolis
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Nagre-recruitPhase 3
- DM Clinical Research - Indianapolis, Indianapolis
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Nagre-recruitPhase 3
- AURORA-1 Clinical Site, Indianapolis
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Nagre-recruitPhase 3
- AURORA-2 Clinical Site, Indianapolis
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Nagre-recruitPhase 2
- Investigators Research Group, Brownsburg · 14 mi ang layo
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Nagre-recruitPhase 4
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
- The Indiana Clinical Trials Center, PC, Plainfield · 14 mi ang layo
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Nagre-recruitPhase 3
- Midwest Inst For Clin Res, Indianapolis
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
Nagre-recruit
- Indiana University, Indianapolis
Pag-aaral para sa Overweight sa ibang lungsod
- San Antonio, TX34 pag-aaral
- Houston, TX33 pag-aaral
- Chicago, IL28 pag-aaral
- Orlando, FL27 pag-aaral
- Las Vegas, NV23 pag-aaral
- Miami, FL23 pag-aaral
- Atlanta, GA20 pag-aaral
- Dallas, TX20 pag-aaral
- New York City, NY19 pag-aaral
- Jacksonville, FL19 pag-aaral
- Washington, DC19 pag-aaral
- Austin, TX18 pag-aaral
Iba pang pag-aaral sa Indianapolis
- Non-Small Cell Lung Cancer32 pag-aaral
- Kanser (lahat ng uri)24 pag-aaral
- Pagkabigo ng Puso23 pag-aaral
- Kanser sa Suso20 pag-aaral
- Obesity20 pag-aaral
- Metastatic Cancer19 pag-aaral
- Colorectal Cancer18 pag-aaral
- Kanser sa Ovary17 pag-aaral
- Kanser sa Baga16 pag-aaral
- Sakit sa Puso at Ugat ng Dugo16 pag-aaral
- Type 1 Diabetes14 pag-aaral
- Kanser ng Endometrium14 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.